• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肝癌的TNM分类]

[TNM classification of liver cancer].

作者信息

Yamasaki S

机构信息

Dept. of Surgical Oncology, National Cancer Center Hospital, Central Tokyo, Japan.

出版信息

Gan To Kagaku Ryoho. 1997 Jul;24(9):1175-82.

PMID:9239174
Abstract

The current TNM classification of the liver was published in 1987 by UICC, which is the same as the staging system in the general Rules for the Clinical and Pathological Study of Primary Liver Cancer by the Liver Cancer Study Group of Japan (3rd Ed.) and was proposed by the Japanese TNM Committee. This was established based upon the data obtained before 1985. Thus, the current TNM classification does not always meet the latest knowledge of advanced hepatic oncology. The disease in which lesions are present both in the left and the right hepatic lobe is defined as Stage 4. Multiple liver cancers of multicentric carcinogenesis which are present in the two hepatic lobe and which are often detected recently, are stage 4 by the current TNM classification. But the postoperative prognosis of this kind of multiple liver cancer is found to be better than that of stage 4 of the advanced type, and equal to stage 3. Some proposals of reversed TNM classification of the liver, made with a small number of experienced cases have been published. However, not all of them would be convincing even with testing of a large number of cases.

摘要

目前的肝脏TNM分类由国际抗癌联盟(UICC)于1987年发布,它与日本肝癌研究组《原发性肝癌临床与病理研究总则》(第3版)中的分期系统相同,由日本TNM委员会提出。这是基于1985年以前获得的数据建立的。因此,目前的TNM分类并不总是符合晚期肝脏肿瘤学的最新知识。左右肝叶均有病变的疾病被定义为IV期。近年来经常检测到的两肝叶多中心发生的多发性肝癌,根据目前的TNM分类属于IV期。但发现这种多发性肝癌的术后预后优于晚期IV期,与III期相当。已经发表了一些对少数经验病例进行的肝脏TNM分类倒置的提议。然而,即使经过大量病例的检验,并非所有提议都能令人信服。

相似文献

1
[TNM classification of liver cancer].[肝癌的TNM分类]
Gan To Kagaku Ryoho. 1997 Jul;24(9):1175-82.
2
Prognostic value of the modified TNM (Izumi) classification of hepatocellular carcinoma in 53 cirrhotic patients undergoing resection.改良TNM(泉井)分类法对53例接受肝切除的肝硬化患者肝细胞癌的预后价值
Hepatogastroenterology. 2001 Jan-Feb;48(37):229-34.
3
Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).肝细胞癌预后分期系统(CLIP评分):其价值与局限性,以及一种新分期系统——日本综合分期评分(JIS评分)的提案。
J Gastroenterol. 2003;38(3):207-15. doi: 10.1007/s005350300038.
4
Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.490例肝细胞癌患者肝移植的结果:手术治疗后统一分期的验证
J Am Coll Surg. 2007 May;204(5):1016-27; discussion 1027-8. doi: 10.1016/j.jamcollsurg.2006.12.043.
5
[Liver cancer--new stage classification according to TNM (UICC)].
Gan No Rinsho. 1986 Aug;32(10):1369-72.
6
The Japanese integrated staging score using liver damage grade for hepatocellular carcinoma in patients after hepatectomy.日本采用肝损伤分级的肝切除术后肝细胞癌综合分期评分。
Eur J Surg Oncol. 2004 Sep;30(7):765-70. doi: 10.1016/j.ejso.2004.05.003.
7
Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.2002年美国癌症联合委员会第6版分期系统对可切除肝细胞癌患者的预后价值及临床意义
J Am Coll Surg. 2006 Oct;203(4):426-35. doi: 10.1016/j.jamcollsurg.2006.06.030. Epub 2006 Aug 23.
8
The Chinese classification system compared with TNM staging in prognosis of patients with primary hepatic carcinoma after resection.中国分类系统与TNM分期在原发性肝癌切除术后患者预后中的比较。
Hepatobiliary Pancreat Dis Int. 2005 Nov;4(4):561-4.
9
Role of Pittsburgh modified TNM criteria in prognosis prediction of liver transplantation for hepatocellular carcinoma.匹兹堡改良TNM标准在肝细胞癌肝移植预后预测中的作用。
Chin Med J (Engl). 2007 Dec 20;120(24):2200-3.
10
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients.AJCC/UICC肝细胞癌TNM分期系统第五版与第六版的比较:对393例接受手术切除的肝硬化患者的多中心研究
Eur J Surg Oncol. 2005 Sep;31(7):760-7. doi: 10.1016/j.ejso.2005.04.008.

引用本文的文献

1
Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database.肝细胞癌肺转移诊断和预后模型的开发与验证:一项基于监测、流行病学和最终结果(SEER)数据库的研究
Front Med (Lausanne). 2023 Jul 19;10:1171023. doi: 10.3389/fmed.2023.1171023. eCollection 2023.
2
Predictive values of serum VEGF and CRP levels combined with contrast enhanced MRI in hepatocellular carcinoma patients after TACE.血清VEGF和CRP水平联合对比增强MRI对TACE术后肝癌患者的预测价值
Am J Cancer Res. 2016 Oct 1;6(10):2375-2385. eCollection 2016.
3
Recurrent Cardiac Tamponade: An Unusual Presentation of Intrahepatic Cholangiocarcinoma.
复发性心脏压塞:肝内胆管癌的一种罕见表现。
ACG Case Rep J. 2016 Apr 15;3(3):205-8. doi: 10.14309/crj.2016.51. eCollection 2016 Apr.